Structural neuroimaging studies of the amygdala and hippocampus in bipolar disorder have been largely inconsistent. This may be due in part to differences in the proportion of subjects taking lithium or experiencing an acute mood state, as both factors have recently been shown to influence gray matter structure. To avoid these problems, we evaluated euthymic subjects not currently taking lithium. Thirty-two subjects with bipolar type I disorder and 32 healthy subjects were scanned using magnetic resonance imaging. Subcortical regions were manually traced, and converted to three-dimensional meshes to evaluate the main effect of bipolar illness on radial distance. Statistical analyses found no evidence for a main effect of bipolar illness in either region, although exploratory analyses found a significant age by diagnosis interaction in the right amygdala, as well as positive associations between radial distance of the left amygdala and both prior hospitalizations for mania and current medication status. These findings suggest that, when not treated with lithium or in an acute mood state, patients with bipolar disorder exhibit no structural abnormalities of the amygdala or hippocampus. Future studies, nevertheless, that further elucidate the impact of age, course of illness, and medication on amygdala structure in bipolar disorder are warranted.
Introduction
Lesion and behavioral studies have implicated the involvement of the amygdala (Flor-Henry, 1969; Bear and Fedio, 1977; Shukla et al., 1987; Starkstein et al., 1988; George et al., 1998; Murphy et al., 1999; Yurgelun-Todd et al., 2000; Lembke and Ketter, 2002) and hippocampus (Flor-Henry, 1969; Bear and Fedio, 1977; Shukla et al., 1987; Starkstein et al., 1988; Altshuler et al., 2005; Malhi et al., 2007) in the pathophysiology of bipolar disorder, but findings from structural neuroimaging studies of these brain regions have been largely inconsistent. Many magnetic resonance imaging (MRI) studies, including our own, have found abnormally large amygdala volumes in adults with bipolar disorder (Altshuler et al., 1998; Strakowski et al., 1999; Brambilla et al., 2003; Frangou, 2005) , but other studies have reported normal (Killgore et al., 2009; Brown et al., 2011) or smaller (Blumberg et al., 2003; Rosso et al., 2007; Savitz et al., 2010) amygdala volumes in adult patients. MRI studies of the hippocampus have also been inconsistent, with volume reductions (Noga et al., 2001; Strasser et al., 2005; Bearden et al., 2008; Chepenik et al., 2009) et al., 1998; Strakowski et al., 1999; Altshuler et al., 2000; Brambilla et al., 2003) reported in bipolar adults compared to healthy controls.
It is not clear why these discrepancies exist, but possibilities include methodological differences (i.e., differences in MRI acquisition and analysis procedures), age or biological factors affecting brain structure (e.g., genetics). Additionally, differences in findings may relate to variations in clinical characteristics of the patient samples. Many prior reports, for example, have sampled from bipolar participants receiving lithium treatment, a mood stabilizing medication known to significantly increase subcortical gray matter volume (Yucel et al., 2007; Bearden et al., 2008; Foland et al., 2008; Usher et al., 2009; Hallahan et al., 2011) . Prior studies have also included patients in various states of mania, depression or euthymia, both within and across studies. This factor (mood state) may also significantly confound results; two recent reports found an effect of acute depression on cortical 
